Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages (Q24290199)

GOA release 2020-03-11

7

M J Thomassen

0 references

author name string

B Raychaudhuri

1

0 references

C J Fisher

2

0 references

C F Farver

3

0 references

A Malur

4

0 references

J Drazba

5

0 references

M S Kavuru

Surface Phenotype Analysis of Human Monocyte to Macrophage Maturation

6

0 references

language of work or name

English

0 references

publication date

September 2000

0 references

published in

Cytokine

0 references

volume

12

0 references

issue

9

0 references

page(s)

1348-55

0 references

cites work

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10.

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

NF-kappa B: a lesson in family values

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Interleukin-10 regulation in normal subjects and patients with asthma

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

NF-kappaB activation: the I kappaB kinase revealed?

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Inflammatory cytokines in cystic fibrosis lungs

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021

The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1006%2FCYTO.2000.0721

7 January 2021